Theratechnologies Inc. (THTX)
Sep 25, 2025 - THTX was delisted (reason: acquired by Future Pak)
3.420
+0.030 (0.88%)
Inactive · Last trade price on Sep 26, 2025
Theratechnologies Revenue
Theratechnologies had revenue of $17.73M in the quarter ending May 31, 2025, a decrease of -19.48%. This brings the company's revenue in the last twelve months to $84.38M, up 2.19% year-over-year. In the fiscal year ending November 30, 2024, Theratechnologies had annual revenue of $85.87M with 5.02% growth.
Revenue (ttm)
$84.38M
Revenue Growth
+2.19%
P/S Ratio
1.75
Revenue / Employee
$819,204
Employees
103
Market Cap
147.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 85.87M | 4.10M | 5.02% |
| Nov 30, 2023 | 81.76M | 1.71M | 2.13% |
| Nov 30, 2022 | 80.06M | 10.23M | 14.66% |
| Nov 30, 2021 | 69.82M | 3.77M | 5.71% |
| Nov 30, 2020 | 66.05M | 2.84M | 4.49% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTHTX News
- 4 weeks ago - Theratechnologies Announces Completion of Acquisition by Future Pak - GlobeNewsWire
- 6 weeks ago - Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewsWire
- 6 weeks ago - Theratechnologies Inc. (TH:CA) Special Meeting Of Shareholders Of Theratechnologies Call (Transcript) - Seeking Alpha
- 6 weeks ago - Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewsWire
- 7 weeks ago - Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy - GlobeNewsWire
- 2 months ago - Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak - GlobeNewsWire
- 2 months ago - Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak - GlobeNewsWire
- 3 months ago - Theratechnologies Reports Financial Results for the Second Quarter 2025 - GlobeNewsWire